Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 59 articles: HTML format

Single Articles

November 2024
1. TESEMA GA, Tessema ZT, Heritier S, Stirling RG, et al
   Timeliness of lung cancer care and area-level determinants in Victoria: A Bayesian spatio-temporal analysis.
   Cancer Epidemiol Biomarkers Prev. 2024.
   PubMed     Abstract available
   
   
   
2. TSAY JJ, Darawshy F, Wang C, Kwok B, et al
   Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma.
   Cancer Epidemiol Biomarkers Prev. 2024;33:1433-1444.
   PubMed     Abstract available
   
   
   September 2024
3. GUDINA AT, Kamen CS, Hirko KA, Adler DH, et al
   Lung Cancer Screening Uptake Under the Revised United States Preventive Service Task Force Guideline: Assessing Disparities.
   Cancer Epidemiol Biomarkers Prev. 2024.
   PubMed     Abstract available
   
   
   August 2024
4. MULVANEY R, Pan Y, Zhao N, Teles F, et al
   Blood Leukocyte DNA Methylation Markers of Periodontal Disease and Risk of Lung Cancer in a Case-Control Study Nested in the CLUE II Cohort.
   Cancer Epidemiol Biomarkers Prev. 2024 Aug 2. doi: 10.1158/1055-9965.EPI-24-0279
   PubMed     Abstract available
   
   
   July 2024
5. TRENDOWSKI MR, Watza D, Lusk CM, Lonardo F, et al
   Evaluation of the Immune Response within the Tumor Microenvironment in African American and non-Hispanic White Non-Small Cell Lung Cancer Patients.
   Cancer Epidemiol Biomarkers Prev. 2024 Jul 2. doi: 10.1158/1055-9965.EPI-24-0333
   PubMed     Abstract available
   
   
   June 2024
6. SMELTZER MP, Akinbobola OA, Ray MA, Fehnel C, et al
   Prevalence of Epidermal Growth Factor Receptor and Programmed Death-Ligand 1 testing in a population-based lung cancer surgical resection cohort from 2018-2022.
   Cancer Epidemiol Biomarkers Prev. 2024.
   PubMed     Abstract available
   
   
   
7. BEKELE BB, Lian M, Shrestha P, Nabi O, et al
   Racialized economic segregation and treatment and outcomes of small-cell lung cancer.
   Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0237
   PubMed     Abstract available
   
   
   
8. PELLINI B, Chaudhuri AA
   Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
   Cancer Epidemiol Biomarkers Prev. 2024;33:769-770.
   PubMed     Abstract available
   
   
   
9. THOMAS AL, Rhee J, Fisher JA, Horner MJ, et al
   Fine Particulate Matter, Noise Pollution, and Greenspace and Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cohort.
   Cancer Epidemiol Biomarkers Prev. 2024;33:857-860.
   PubMed     Abstract available
   
   
   May 2024
10. MURPHY SE, Guillermo C, Thomson NM, Carmella SG, et al
    Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    April 2024
11. WANG J, Wang Q, Shi Z, Yan X, et al
    Serum lipid levels, genetic risk, and lung cancer incidence: A large prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
12. ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
    Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey Data.
    Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
    PubMed     Abstract available
    
    
    February 2024
13. BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
    Association between Airport Ultrafine Particles and Lung Cancer Risk: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
14. PELLAND-ST-PIERRE L, Pham MC, Nguyen AQH, Pasquet R, et al
    The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the AHRR and F2RL3 Genes.
    Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
    PubMed     Abstract available
    
    
    
15. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed     Abstract available
    
    
    January 2024
16. YOON HS, Wu J, Shidal C, Sun Y, et al
    Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
17. LIU Q, Medina HN, Rodriguez E, Jacobs KT, et al
    Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
18. DUNCAN MS, Diaz-Zabala H, Jaworski J, Tindle HA, et al
    INTERACTION BETWEEN CONTINUOUS PACK-YEARS SMOKED AND POLYGENIC RISK SCORE ON LUNG CANCER RISK: PROSPECTIVE RESULTS FROM THE FRAMINGHAM HEART STUDY.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
19. GRABSKI IN, Heymach JV, Kehl KL, Kopetz S, et al
    Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum.
    Cancer Epidemiol Biomarkers Prev. 2024;33:158-169.
    PubMed     Abstract available
    
    
    
20. LI Y, Xiao X, Li J, Han Y, et al
    Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
    Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0613
    PubMed     Abstract available
    
    
    November 2023
21. YANG Z, He H, He G, Zeng C, et al
    Investigating Causal Effects of Hematological Traits on Lung Cancer: A Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 1. doi: 10.1158/1055-9965.EPI-23-0725
    PubMed     Abstract available
    
    
    September 2023
22. WONG JY, Shu XO, Hu W, Blechter B, et al
    Associations between longer leukocyte telomere length and increased lung cancer risk among never smokers in urban China.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available
    
    
    August 2023
23. TRENDOWSKI MR, Lusk CM, Wenzlaff AS, Neslund-Dudas C, et al
    Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 14:EPI-23-0174.
    PubMed     Abstract available
    
    
    
24. PETTIT RW, Byun J, Han Y, Ostrom QT, et al
    Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 2:EPI-22-0698.
    PubMed     Abstract available
    
    
    July 2023
25. SEDETA E, Sung H, Laversanne M, Bray F, et al
    Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide.
    Cancer Epidemiol Biomarkers Prev. 2023;32:894-905.
    PubMed     Abstract available
    
    
    June 2023
26. SALVATORE M, Hu MM, Beesley LJ, Mondul AM, et al
    COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination.
    Cancer Epidemiol Biomarkers Prev. 2023;32:748-759.
    PubMed     Abstract available
    
    
    May 2023
27. SHARIFIAN N, Carey FR, Seay JS, Castaneda SF, et al
    Risk and Protective Factors for Cancer Mortality among United States Service Members and Veterans (2001-2018).
    Cancer Epidemiol Biomarkers Prev. 2023;32:606-616.
    PubMed     Abstract available
    
    
    
28. LUO R, Zhong P, Li X, Cai J, et al
    High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2023;32:726-738.
    PubMed     Abstract available
    
    
    April 2023
29. LI FX, Zhao HY, Lin TF, Jiang YW, et al
    Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort.
    Cancer Epidemiol Biomarkers Prev. 2023;32:531-541.
    PubMed     Abstract available
    
    
    March 2023
30. ETEMADI A, Abnet CC, Dawsey SM, Freedman ND, et al
    Biomarkers of Tobacco Carcinogenesis in Diverse Populations: Challenges and Opportunities.
    Cancer Epidemiol Biomarkers Prev. 2023;32:289-291.
    PubMed     Abstract available
    
    
    December 2022
31. CHANDRAN U, Reps J, Yang R, Vachani A, et al
    Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 28:EPI-22-0873.
    PubMed     Abstract available
    
    
    
32. MARMOR HN, Deppen SA, Welty V, Kammer MN, et al
    Improving Lung Cancer Diagnosis with Computed Tomography Radiomics and Serum Histoplasmosis Testing.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 16:EPI-22-0532.
    PubMed     Abstract available
    
    
    
33. RUEL LJ, Li Z, Gaudreault N, Henry C, et al
    Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2219-2227.
    PubMed     Abstract available
    
    
    November 2022
34. SHREVES AH, Buller ID, Chase E, Creutzfeldt H, et al
    Geographic Patterns in U.S. Lung Cancer Mortality and Cigarette Smoking.
    Cancer Epidemiol Biomarkers Prev. 2022 Nov 22:EPI-22-0253.
    PubMed     Abstract available
    
    
    
35. CIGAN SS, Murphy SE, Stram DO, Hecht SS, et al
    Association of urinary biomarkers of smoking-related toxicants with lung cancer incidence in smokers: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Nov 9. pii: 710531.
    PubMed     Abstract available
    
    
    September 2022
36. CHIEN LH, Chen TY, Chen CH, Chen KY, et al
    Recalibrating risk prediction models by synthesizing data sources: adapting the lung cancer PLCO model for Taiwan.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 21. pii: 709337.
    PubMed     Abstract available
    
    
    
37. FORTUNATO O, Huber V, Segale M, Cova A, et al
    Development of a molecular blood-based immune signature classifier as biomarker for risks assessment in Lung Cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 16. pii: 708821.
    PubMed     Abstract available
    
    
    
38. SHOME M, Gao W, Engelbrektson A, Song L, et al
    Comparative microbiomics analysis of anti-microbial antibody response between lung cancer patients and control subjects with benign pulmonary nodules.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 3. pii: 709014.
    PubMed     Abstract available
    
    
    August 2022
39. ZHOU B, Lu J, Beck JD, Moss KL, et al
    Periodontal and other oral bacteria and risk of lung cancer in the Atherosclerosis Risk in Communities (ARIC) Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 23. pii: 708566.
    PubMed     Abstract available
    
    
    
40. BEABER EF, Kamineni A, Burnett-Hartman AN, Hixon B, et al
    Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1521-1531.
    PubMed     Abstract available
    
    
    July 2022
41. SMITH-BYRNE K, Cerani A, Guida F, Zhou S, et al
    Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Pre-Diagnostic Blood Measurements.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 15. pii: 707037.
    PubMed     Abstract available
    
    
    June 2022
42. BACKENROTH D, Snider J, Shen R, Seshan V, et al
    Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1195-1201.
    PubMed     Abstract available
    
    
    May 2022
43. DU Y, Sidorenkov G, Groen HJ, Heuvelmans MA, et al
    Airflow limitation increases lung cancer risk in smokers: the Lifelines cohort study.
    Cancer Epidemiol Biomarkers Prev. 2022 May 9. pii: 696484.
    PubMed     Abstract available
    
    
    April 2022
44. MUKHERJEE S, Bandlamudi C, Hellmann MD, Kemel Y, et al
    Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 27. pii: 694787.
    PubMed     Abstract available
    
    
    
45. OLSSON A, Guha N, Bouaoun L, Kromhout H, et al
    Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: results from a pooled analysis of case-control studies (SYNERGY).
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 18. pii: 694483.
    PubMed     Abstract available
    
    
    
46. HUNG RJ
    Biomarker-Based Lung Cancer Screening Eligibility: Implementation Considerations.
    Cancer Epidemiol Biomarkers Prev. 2022;31:698-701.
    PubMed     Abstract available
    
    
    January 2022
47. PEERI NC, Tao MH, Demissie S, Nguyen UD, et al
    Sleep duration, chronotype, and insomnia and the risk of lung cancer: United Kingdom Biobank Cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 27. pii: 1055-9965.EPI-21-1093.
    PubMed     Abstract available
    
    
    
48. JACOBSEN KK, Schnohr P, Jensen GB, Bojesen SE, et al
    AHRR (cg5575921) methylation safely improves specificity of lung cancer screening eligibility criteria: A cohort study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-1059.
    PubMed     Abstract available
    
    
    
49. SCHMID S, Jiang M, Brown MC, Fares A, et al
    Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-0747.
    PubMed     Abstract available
    
    
    December 2021
50. INOUE K, Hsu W, Arah OA, Prosper AE, et al
    Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2227-2234.
    PubMed     Abstract available
    
    
    November 2021
51. YUAN Q, Du M, Loehrer E, Johnson BE, et al
    Post-diagnosis BMI change is associated with non-small cell lung cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 2. pii: 1055-9965.EPI-21-0503.
    PubMed     Abstract available
    
    
    September 2021
52. GHOSH T, Chen Y, Dietz AC, Armstrong GT, et al
    Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 14. pii: 1055-9965.EPI-21-0250.
    PubMed     Abstract available
    
    
    August 2021
53. FAN Y, Su Z, Wei M, Liang H, et al
    Long-term lung cancer risk associated with sputum atypia: a 27-year follow-up study of an occupational lung screening cohort in Yunnan, China.
    Cancer Epidemiol Biomarkers Prev. 2021 Aug 26. pii: 1055-9965.EPI-21-0339.
    PubMed     Abstract available
    
    
    June 2021
54. ABE SK, Narita S, Saito E, Sawada N, et al
    Body mass index, height, weight change, and subsequent lung cancer risk: the Japan Public Health Center-based Prospective Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 25. pii: 1055-9965.EPI-21-0195.
    PubMed     Abstract available
    
    
    
55. WOOD AM, Jonsson H, Nagel G, Haggstrom C, et al
    The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 22. pii: 1055-9965.EPI-21-0058.
    PubMed     Abstract available
    
    
    
56. ZHANG EW, Shepard JO, Kuo A, Chintanapakdee W, et al
    Characteristics and outcomes of lung cancers detected on low-dose lung cancer screening CT.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 9. pii: 1055-9965.EPI-20-1847.
    PubMed     Abstract available
    
    
    
57. ERHUNMWUNSEE L, Wing SE, Shen J, Hu H, et al
    The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 4. pii: 1055-9965.EPI-20-1555.
    PubMed     Abstract available
    
    
    May 2021
58. DEROUEN MC, Thompson CA, Canchola AJ, Jin A, et al
    Integrating electronic health record, cancer registry, and geospatial data to study lung cancer in Asian American, Native Hawaiian and Pacific Islander ethnic groups.
    Cancer Epidemiol Biomarkers Prev. 2021 May 17. pii: 1055-9965.EPI-21-0019.
    PubMed     Abstract available
    
    
    April 2021
59. WILUNDA C, Sawada N, Yamaji T, Iwasaki M, et al
    Reproductive factors and lung cancer risk among never-smoking Japanese women with 21 years of follow-up: a cohort study.
    Cancer Epidemiol Biomarkers Prev. 2021 Apr 7. pii: 1055-9965.EPI-20-1399.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.